位置:首页 > 蛋白库 > CDC23_CAEEL
CDC23_CAEEL
ID   CDC23_CAEEL             Reviewed;         673 AA.
AC   Q19294;
DT   20-JAN-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   03-AUG-2022, entry version 159.
DE   RecName: Full=Cell division cycle protein 23 homolog {ECO:0000303|PubMed:11134076};
DE   AltName: Full=Anaphase-promoting complex subunit 8 {ECO:0000250|UniProtKB:Q9UJX2};
DE            Short=APC8 {ECO:0000250|UniProtKB:Q9UJX2};
DE   AltName: Full=Metaphase-to-anaphase transition defect protein 3 {ECO:0000312|WormBase:F10C5.1};
GN   Name=mat-3 {ECO:0000312|WormBase:F10C5.1};
GN   Synonyms=apc-8 {ECO:0000312|WormBase:F10C5.1},
GN   cdc-23 {ECO:0000312|WormBase:F10C5.1},
GN   pod-4 {ECO:0000312|WormBase:F10C5.1}, vex-2 {ECO:0000312|WormBase:F10C5.1};
GN   ORFNames=F10C5.1 {ECO:0000312|WormBase:F10C5.1};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF SER-502.
RX   PubMed=11134076; DOI=10.1083/jcb.151.7.1469;
RA   Golden A., Sadler P.L., Wallenfang M.R., Schumacher J.M., Hamill D.R.,
RA   Bates G., Bowerman B., Seydoux G., Shakes D.C.;
RT   "Metaphase to anaphase (mat) transition-defective mutants in Caenorhabditis
RT   elegans.";
RL   J. Cell Biol. 151:1469-1482(2000).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11832245; DOI=10.1016/s1534-5807(02)00114-4;
RA   Rappleye C.A., Tagawa A., Lyczak R., Bowerman B., Aroian R.V.;
RT   "The anaphase-promoting complex and separin are required for embryonic
RT   anterior-posterior axis formation.";
RL   Dev. Cell 2:195-206(2002).
RN   [4] {ECO:0000305}
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-70; GLU-161;
RP   GLU-237; ALA-339; GLU-401; ALA-451; SER-502; ALA-528 AND GLY-532.
RX   PubMed=11861581; DOI=10.1093/genetics/160.2.805;
RA   Davis E.S., Wille L., Chestnut B.A., Sadler P.L., Shakes D.C., Golden A.;
RT   "Multiple subunits of the Caenorhabditis elegans anaphase-promoting complex
RT   are required for chromosome segregation during meiosis I.";
RL   Genetics 160:805-813(2002).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=15556870; DOI=10.1016/j.cub.2004.11.010;
RA   Juo P., Kaplan J.M.;
RT   "The anaphase-promoting complex regulates the abundance of GLR-1 glutamate
RT   receptors in the ventral nerve cord of C. elegans.";
RL   Curr. Biol. 14:2057-2062(2004).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15238519; DOI=10.1534/genetics.103.026021;
RA   Garbe D., Doto J.B., Sundaram M.V.;
RT   "Caenorhabditis elegans lin-35/Rb, efl-1/E2F and other synthetic multivulva
RT   genes negatively regulate the anaphase-promoting complex gene mat-3/APC8.";
RL   Genetics 167:663-672(2004).
RN   [7] {ECO:0000305}
RP   MUTAGENESIS OF LEU-433 AND SER-502.
RX   PubMed=17057243; DOI=10.1534/genetics.106.059105;
RA   Stein K.K., Davis E.S., Hays T., Golden A.;
RT   "Components of the spindle assembly checkpoint regulate the anaphase-
RT   promoting complex during meiosis in Caenorhabditis elegans.";
RL   Genetics 175:107-123(2007).
RN   [8] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=24321454; DOI=10.1016/j.mcn.2013.12.001;
RA   Kowalski J.R., Dube H., Touroutine D., Rush K.M., Goodwin P.R., Carozza M.,
RA   Didier Z., Francis M.M., Juo P.;
RT   "The anaphase-promoting complex (APC) ubiquitin ligase regulates GABA
RT   transmission at the C. elegans neuromuscular junction.";
RL   Mol. Cell. Neurosci. 58:62-75(2014).
CC   -!- FUNCTION: Probable component of the anaphase promoting
CC       complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase
CC       that controls progression through mitosis and the G1 phase of the cell
CC       cycle (PubMed:11861581, PubMed:15238519). The APC/C complex acts by
CC       mediating ubiquitination and subsequent degradation of target proteins
CC       (PubMed:11861581). Developmental role in early embryogenesis and the
CC       metaphase to anaphase transition in oocyte and spermatocyte meiosis and
CC       mitosis in germ cells (PubMed:11134076, PubMed:11861581,
CC       PubMed:15238519). Required for embryonic anterior-posterior axis
CC       formation (PubMed:11832245). Plays a role in regulating the abundance
CC       of glr-1 receptors in postmitotic neurons, which may in turn control
CC       animal locomotion (PubMed:15556870). Involved in regulating GABA
CC       neurotransmitter release at neuromuscular junctions in GABA motor
CC       neurons (PubMed:24321454). {ECO:0000269|PubMed:11134076,
CC       ECO:0000269|PubMed:11832245, ECO:0000269|PubMed:11861581,
CC       ECO:0000269|PubMed:15238519, ECO:0000269|PubMed:15556870,
CC       ECO:0000269|PubMed:24321454}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination. {ECO:0000305}.
CC   -!- SUBUNIT: The APC/C complex is probably composed of at least 12
CC       subunits: apc-2, apc-10, apc-11, cdc-26, emb-1, emb-27, emb-30, mat-1,
CC       mat-2, mat-3, such-1 and gfi-3. {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Developmental defects in the gonad, germline,
CC       male tail and hermaphrodite vulva (PubMed:15238519). Increased number
CC       of germ cells arrested at the metaphase stage of mitosis during the
CC       larval stage L4; by adulthood, there are no nuclei in the distal part
CC       of the gonad and as a result, no sperm or oocytes are formed
CC       (PubMed:15238519). RNAi-mediated knockdown results in defective
CC       metaphase to anaphase transition (Mat phenotype) and embryos that
CC       arrest at the one-cell stage that display defects in the formation of
CC       the anterior-posterior axis (PubMed:11861581, PubMed:11832245).
CC       {ECO:0000269|PubMed:11832245, ECO:0000269|PubMed:11861581,
CC       ECO:0000269|PubMed:15238519}.
CC   -!- SIMILARITY: Belongs to the APC8/CDC23 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FO081107; CCD69151.1; -; Genomic_DNA.
DR   RefSeq; NP_497203.1; NM_064802.4.
DR   AlphaFoldDB; Q19294; -.
DR   SMR; Q19294; -.
DR   ComplexPortal; CPX-3382; Anaphase Promoting Complex/Cyclosome.
DR   DIP; DIP-24631N; -.
DR   IntAct; Q19294; 2.
DR   STRING; 6239.F10C5.1; -.
DR   EPD; Q19294; -.
DR   PaxDb; Q19294; -.
DR   PeptideAtlas; Q19294; -.
DR   EnsemblMetazoa; F10C5.1.1; F10C5.1.1; WBGene00003134.
DR   GeneID; 175205; -.
DR   KEGG; cel:CELE_F10C5.1; -.
DR   UCSC; F10C5.1; c. elegans.
DR   CTD; 175205; -.
DR   WormBase; F10C5.1; CE26888; WBGene00003134; mat-3.
DR   eggNOG; KOG1155; Eukaryota.
DR   GeneTree; ENSGT00950000182950; -.
DR   HOGENOM; CLU_018320_3_0_1; -.
DR   InParanoid; Q19294; -.
DR   OMA; MWTNEIL; -.
DR   OrthoDB; 761109at2759; -.
DR   PhylomeDB; Q19294; -.
DR   Reactome; R-CEL-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q19294; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q19294; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00003134; Expressed in germ line (C elegans) and 4 other tissues.
DR   GO; GO:0005680; C:anaphase-promoting complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; IBA:GO_Central.
DR   GO; GO:0008356; P:asymmetric cell division; IMP:UniProtKB.
DR   GO; GO:0051301; P:cell division; IBA:GO_Central.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW.
DR   GO; GO:0009949; P:polarity specification of anterior/posterior axis; IMP:UniProtKB.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0051445; P:regulation of meiotic cell cycle; IC:ComplexPortal.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IC:ComplexPortal.
DR   GO; GO:1904666; P:regulation of ubiquitin protein ligase activity; IC:ComplexPortal.
DR   Gene3D; 1.25.40.10; -; 2.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF13181; TPR_8; 2.
DR   SMART; SM00028; TPR; 7.
DR   SUPFAM; SSF48452; SSF48452; 2.
DR   PROSITE; PS50005; TPR; 5.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Developmental protein; Meiosis; Mitosis;
KW   Neurotransmitter transport; Reference proteome; Repeat; TPR repeat;
KW   Transport; Ubl conjugation pathway.
FT   CHAIN           1..673
FT                   /note="Cell division cycle protein 23 homolog"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000435330"
FT   REPEAT          86..120
FT                   /note="TPR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          159..195
FT                   /note="TPR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          232..267
FT                   /note="TPR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          332..365
FT                   /note="TPR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          400..433
FT                   /note="TPR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          434..467
FT                   /note="TPR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          469..501
FT                   /note="TPR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          502..535
FT                   /note="TPR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          539..572
FT                   /note="TPR 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          577..610
FT                   /note="TPR 10"
FT                   /evidence="ECO:0000255"
FT   REGION          628..673
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        654..673
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         70
FT                   /note="E->K: In or192; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         161
FT                   /note="E->K: In ax68; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         237
FT                   /note="E->K: In ax82; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         339
FT                   /note="A->L: In ax77; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         401
FT                   /note="E->K: In ax79 and ax136; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         433
FT                   /note="L->F: In av26; weak suppressor of mat-3 mutations."
FT                   /evidence="ECO:0000269|PubMed:17057243"
FT   MUTAGEN         451
FT                   /note="A->V: In ax70; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         502
FT                   /note="S->F: In or172, or180 and or187; maternal-effect
FT                   embryonic lethal."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         502
FT                   /note="S->F: In or180; embryonic lethal."
FT                   /evidence="ECO:0000269|PubMed:11134076,
FT                   ECO:0000269|PubMed:17057243"
FT   MUTAGEN         528
FT                   /note="A->T: In ax148; maternal-effect embryonic lethal."
FT                   /evidence="ECO:0000269|PubMed:11861581"
FT   MUTAGEN         532
FT                   /note="G->D: In ax71; results in sterility."
FT                   /evidence="ECO:0000269|PubMed:11861581"
SQ   SEQUENCE   673 AA;  76993 MW;  D76FAA6D4892E5FA CRC64;
     MNVSFSTPVQ NSTASRLALI QQAAARSGAL PPAGQYRGSK LSPFDVSQMS GVSISMVERA
     KINGPEFVEE LEWLRQQTTS RCFLDAEMWT NEILAHLPDK WCAPNTLNLY NQVSELVLDN
     TRSPMASPAS NSLYAPGEDQ MPTVKRNHTS RFAQSLIKNK EFRRAAFFLE KTMNGNKLDH
     FLHFRCLFLA YYQEHLENDA EGIERKTSFA EERSPFSLLY QRMEDKKLRE NEDVWFEYLM
     GLLEVELGLK DLAEKSFRNV VIREPRIWPA WEALSRLIAD IEDADKFVTS AEVKSLWMGD
     WFMTLVLQRF HQHSMAIQKA EQLVTRGMTG LPMIITKIAA CSNARHDHDQ AISNFEDVRK
     ADPYRLGDLH LLSDSLYIRN DQKKLSTLAI EVYKVHKFRW ETCCIVANYH AIRRDSEHAI
     KFFQRALRLN PGLAALWVLI GHEFMEMKNN AAACVSYRRA IEIDPADHRG WYGLGQMYDI
     MKMPAYALFY YQEAQKCKPH DSRLLVALGD IYSKLNRIED AEKCFTGAYL FGDVEGNALW
     SLAKLHERYS DDNKAAQAFE VFLVVYELVT SAEEKIIYAI AFLANHFFKI EDFDKASEYA
     TKCLAFETLC QEGNRLFREI AKIQARESRL PVEEAPGPSN ASAAGGQEAM DTEEAPQEGG
     EEEMSEGEDD FSF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024